5 Key Takeaways

• 1

  A study presented at ACC 2024 examined the risk of cardiomyopathy in young adults with ADHD treated with stimulants.

• 2

  The study analyzed 12,759 patients aged 20 to 40 diagnosed with ADHD who received stimulant treatment.

• 3

  Patients treated with stimulants were found to have a 17% and 57% higher likelihood of developing cardiomyopathy after 1 and 8 years, respectively.

• 4

  The overall risk of cardiomyopathy was low in both stimulant (0.72%) and nonstimulant (0.53%) treatment groups.

• 5

  The findings suggest that physicians may not need to change their screening and prescribing practices for cardiomyopathy.